Critical Class Action Notice for PepGen Inc. Shareholders – Act Before August 2025 Deadline
Important Class Action Alert for PepGen Inc. Shareholders
PepGen Inc. (NASDAQ: PEPG) shareholders should be aware of an urgent class action notice issued by The Gross Law Firm. If you purchased shares during the previously specified class period, it’s vital that you consider joining this legal action to protect your investment. The deadline to register is August 8, 2025.
Background Information
The class action pertains to allegations against PepGen Inc. concerning misleading information that may have significantly affected stock values. Specifically, the claim revolves around the company’s lead product candidate, PGN-EDO51, which is alleged to have been marketed as being more effective and safe than its true capabilities. This misrepresentation is claimed to have influenced investor decisions unknowingly.
Key Dates and Procedures
The class period in question spans from March 7, 2024, to March 3, 2025. During this timeframe, shareholders are encouraged to report their losses. Registering as a shareholder does not necessarily entail a financial burden; instead, it opens the door to potential recovery in the event of a favorable outcome.
To join the class action, shareholders should visit the dedicated registration page here. This registration will not only keep shareholders informed about the case but also enroll them in a portfolio monitoring service that tracks updates throughout the litigation process.
Allegations
The complaint put forth alleges several significant points:
1. Inaccurate Efficacy Claims: The claims made about the effectiveness and safety of PGN-EDO51 were exaggerated, painting a misleading picture of the product's actual performance.
2. Concerns Over Clinical Trials: The second phase of the CONNECT2 study is said to have been flawed or dangerous, jeopardizing its approval by the U.S. Food and Drug Administration (FDA).
3. Market Impact: Due to the aforementioned issues, there were indications that PepGen might have to suspend the CONNECT2 study simplifying the false confidence investors held regarding PGN-EDO51’s prospects.
4. Misguided Statements: Public statements from the company during this period were described as materially false and misleading, which could have artificially inflated the company’s stock prices.
No Upfront Fees
It is critical for shareholders to realize that participating in this lawsuit does not come with upfront costs. The Gross Law Firm emphasizes that they operate on a contingency basis, meaning they only recover fees if the case results in a successful outcome for investors. This demonstrates a commitment to the mishandled interests of investors and reflects the firm’s overall mission to uphold corporate accountability.
Why Choose The Gross Law Firm?
The Gross Law Firm is a reputable name in class action lawsuits, known for its advocacy on behalf of investors who have lost money due to fraudulent activity. With a strong track record in successfully representing clients, the firm's intention is to recover losses incurred by PepGen shareholders and to demand corporate accountability for misleading practices.
For more information or to discuss your case, interested parties can reach The Gross Law Firm at:
- - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
- - Email: [email protected]
- - Phone: (646) 453-8903
Conclusion
PepGen Inc. shareholders must act promptly—time is of the essence as the deadline approaches. By joining this class action, you ensure that your voice is heard and your rights as an investor are protected. Don't miss this critical opportunity to safeguard your investments against misleading corporate behavior.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.